Keywords Lobular breast cancer cyclin-dependent kinase 4/6 inhibitor abemaciclib ribociclib palbociclib real-world outcomes Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Tan, P.H. ∙ Ellis, I. ∙ Allison, K. ... The 2019 World Health Organization classification of tumours of the breast Histopathology. 2020; 77(2):181-185 2. Weigelt, B. ∙ Horlings, H.M. ∙ Kreike, B. ...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Claudia
Contact Claudia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack